EDUCATING LEADERS IN PHARMACY AND PHARMACEUTICAL SCIENCES SINCE 1886
Clinical Management of Concussion and Persistent Post-Concussive Symptoms
Online enduring activity
Start date: March 1, 2024
End date: February 28, 2025
Target Audience
Physicians, nurses, pharmacists, physician assistants, physical therapists/PTA, speech language pathologists/audiologists, social workers, occupational therapists/OTA, licensed psychologists, and athletic trainers.
Why you should attend
The science of concussion is advancing rapidly and there is a need for easily accessible, flexible instruction courses for the many providers that care for these patients. Early detection and diagnosis, along with management results in better outcomes. Research demonstrates that more than two-thirds of all patients do not seek medical follow-up or clearance as recommended by current concussion guidelines. Pediatric emergency physicians diagnosed concussion approximately 50% less often relative to international consensus-based guidelines and used a limited number of variables to make this diagnosis when compared with current recommendations. Recent study indicates that earlier initiation of clinical care is associated with faster recovery after concussion.
On this page:
Objectives
- Discuss the evidence-based treatments for concussion and the causes of the symptoms, also known as "symptom generators" in those suffering Persisting Post-Concussion Symptoms (PPCS).
- Define an approach to helping students Return to Learn (School).
- Identify approaches to help students Return to Sport.
Program Schedule
This activity contains a pre-test, educational material, educational video, a post-test, and a program evaluation. Successful achievement of this activity requires achieving a score of 70% or higher on the post-test.
Presenter
John J. Leddy, MD, FACSM, FACP, FAMSSM
Cost and Support
There is no fee for this program and there is no commercial support associated with this educational activity. The Concussion Outreach Prevention Education (COPE) project is supported by funding provided by the New York State Department of Health, in collaboration with the New York State Senate.
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. Relevant financial relationships exist between the following individuals and commercial interests:
Faculty Disclosures
John Leddy, MD discloses: Grants: NIH, Department of Defense; Consultant: Neurolign; Stock Shareholder (directly purchased): 360 Concussion Care
Planning Committee Disclosures
James Noble, MD discloses Stock Shareholder (directly purchased): stock options in Bats Toi
Louis Corsaro MD, Steven Flanagan, MD, John Leddy, MD, Jake McPherson, PT, DPT, PhD, Matt Hickling, CPNP-PC, MSN, RN, Christina LeBeau, Michelle Kellen, M.Ed., Candice Gillett, MPH and Marsha Nelson have nothing to disclose.
Content Reviewer Disclosures
Scott J Hershman, MD, FACEHP, CHCP has nothing to disclose.
Alexia Sroka, PharmD, BCPS, has nothing to disclose.
*All relevant financial relationships have been mitigated.
Unlabeled Use Disclosure
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, the faculty, and Brain Injury Association of New York State, LLC. do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Accreditation Information
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been accredited as a knowledge-based activity. Credit will be uploaded to the CPE Monitor to those who complete a all components of this activity. No partial credit is available.
ACPE# 0044-9999-24-006-H01-P, 1.0 Contact hour, 0.1 ceu.
In support of improving patient care, this activity has been planned and implemented by The Brain Injury Association of New York State, LLC. and CME Outfitters, LLC. CME Outfitters LLC. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians (ACCME): CME Outfitters, LLC designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 Credit TM through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit TM from Jointly Accredited Organizations. Nurse practitioners can also apply for credit through their state boards.
This activity is designated for 1 contact hours.
Physician Associates/Assistants: CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid until February, 28, 2025. PAs should only claim credit commensurate with the extent of their participation.
NYSATA (BOC AP# P315) is approved by the Board of Certification, Inc. to provide continuing education to Athletic Trainers. Each module is eligible for a maximum of 1 Category A hours/CEUs
BIANYS is recognized by the New York State Education Department’s Office of the Professions as a provider for continuing competencies in the following areas: Social Work (#0539), Physical Therapy/ PT Assistants, Speech-Language Pathologist & Audiologists, and Occupational Therapy/ OT assistants. Certificates will be provided through BIANYS
Questions?
Please email pharmacyce@buffalo.edu